लोड हो रहा है...
Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?
Atorvastatin and direct oral factor Xa inhibitors (xabans) are frequently co‐administrated in patients with atrial fibrillation (AF). However, no studies investigating the possibility of the pharmacologic interaction between these agents have been conducted. The aim of this prospective observational...
में बचाया:
| में प्रकाशित: | Pharmacol Res Perspect |
|---|---|
| मुख्य लेखकों: | , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley and Sons Inc.
2021
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8118196/ https://ncbi.nlm.nih.gov/pubmed/33984191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.730 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|